MARC details
000 -LIDER |
fixed length control field |
03318nam a22004455i 4500 |
001 - CONTROL NUMBER |
control field |
978-3-319-46505-0 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
DE-He213 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20180206183058.0 |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr nn 008mamaa |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
161128s2016 gw | s |||| 0|eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9783319465050 |
-- |
978-3-319-46505-0 |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RC261-271 |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MJCL |
Source |
bicssc |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MED062000 |
Source |
bisacsh |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
614.5999 |
Edition number |
23 |
245 10 - TITLE STATEMENT |
Title |
Resistance to Targeted Therapies Against Adult Brain Cancers |
Medium |
[recurso electrónico] / |
Statement of responsibility, etc. |
edited by Amanda Tivnan. |
264 #1 - |
-- |
Cham : |
-- |
Springer International Publishing : |
-- |
Imprint: Springer, |
-- |
2016. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
XVI, 260 p. 19 illus., 16 illus. in color. |
Other physical details |
online resource. |
336 ## - |
-- |
text |
-- |
txt |
-- |
rdacontent |
337 ## - |
-- |
computer |
-- |
c |
-- |
rdamedia |
338 ## - |
-- |
online resource |
-- |
cr |
-- |
rdacarrier |
347 ## - |
-- |
text file |
-- |
PDF |
-- |
rda |
490 1# - SERIES STATEMENT |
Series statement |
Resistance to Targeted Anti-Cancer Therapeutics, |
International Standard Serial Number |
2196-5501 |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Targeted therapies in gliomas: An overview -- Targeting chemotherapy resistance in glioblastoma through modulation of ABC transporters -- Resistance of Glioblastomas to Radiation Therapy -- The blood-brain barrier in glioblastoma multiforme: Pathology and therapeutic implications -- Resistance of brain tumours to small-molecule targeted therapies: lessons from various cancer types -- Drug repurposing to circumvent chemotherapy resistance in brain tumours -- Small molecule inhibitors in glioblastoma: Key pathways and resistance mechanisms -- Imaging Targeted Therapy Response and Resistance in Glioblastoma -- Drug Resistance in Malignant Meningiomas -- Recurrence of Low-Grade Glioma - Have the Targeted Therapies Improved for Better Outcomes? -- Host-Tumor Interactions in Brain Cancer Metastasis Leading to Drug Resistance. |
520 ## - SUMMARY, ETC. |
Summary, etc. |
This volume will bring together a review of research being carried out by international experts in this field, detailing treatment and research approaches in several forms of malignant brain tumors. These include glioblastoma (GBM), a highly aggressive and fatal form of astrocytoma which accounts for 80% of newly diagnosed brain tumor patients per year, and meningioma, of which 10% are malignant and extremely resistant to targeted therapies. The volume will also include a discussion of methods to overcome blood-brain barrier exclusion for more efficient targeted drug delivery in all forms of brain cancer treatment. The volume will include information on the repurposing of drugs in an attempt to circumvent drug resistance, use of small molecule inhibitors in GBM treatment, mechanisms of secondary brain metastasis, drug resistance, and state-of-the-art imaging of targeted therapies. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Término temático o nombre geográfico como elemento de entrada |
Medicine. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Término temático o nombre geográfico como elemento de entrada |
Cancer research. |
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Término temático o nombre geográfico como elemento de entrada |
Biomedicine. |
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Término temático o nombre geográfico como elemento de entrada |
Cancer Research. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Tivnan, Amanda. |
Relator term |
editor. |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
773 0# - HOST ITEM ENTRY |
Title |
Springer eBooks |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
Relationship information |
Printed edition: |
International Standard Book Number |
9783319465043 |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
Uniform title |
Resistance to Targeted Anti-Cancer Therapeutics, |
-- |
2196-5501 |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Public note |
Libro electrónico |
Uniform Resource Identifier |
http://148.231.10.114:2048/login?url=http://dx.doi.org/10.1007/978-3-319-46505-0 |
912 ## - |
-- |
ZDB-2-SBL |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Koha item type |
Libro Electrónico |